How Stereotaxis Is Making Its Mark in Surgical Robotics: A Journey from Survival to Success
David Fischel, CEO of Stereotaxis, shares the company's story of overcoming challenges in the surgical robotics market on Let's Talk Medtech. He details their recent $50 million funding round, collaborations with NVIDIA, and his outlook on the future of surgical robotics.